Published 6-9-2020
Dateline:
Krakow, Poland
Ryvu Therapeutics completed construction in June of 2020 on the R&D Center for Innovative Drugs in Krakow, Poland. Accommodating approximately 300 employees, the $20 million headquarters and research facility will enable the clinical-stage biopharmaceutical company to accelerate the development of novel small molecule therapies that address emerging targets in oncology. The six-story, 108,000-sf structure includes offices, technical suites, social areas, and 32,300 sf of lab space for medicinal chemistry, biochemistry, analytical chemistry, and cell and molecular biology.
Questions or Comments? Contact the Editor
Sources: